Healthy Japanese adult
Conditions
Interventions
Take the plant extract-containing food for 4 weeks to confirm safety.
Sponsors
Oneness support CO., LTD
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Healthy men and women aged 20 to 79 years old (2) BMI less than 30 (3) A person who has received a sufficient explanation of the purpose and contents of the study, has the ability to consent, voluntarily participates in a well-understood manner, and consents to the examination
Exclusion criteria
Exclusion criteria: (1) Liver disease, kidney disease, digestive system disease, heart disease, respiratory disorder, endocrine disorder, metabolic disorder, neurological disorder, consciousness disorder, diabetes, seizures, and other diseases that may affect the results of this test Person who has a medical history or who has a history of surgery (2) Patients who have been hospitalized for treatment due to stroke, subarachnoid hemorrhage, cerebral infarction, cerebral hemorrhage, brain contusion, head injury (3) Those who show abnormal liver function and renal function test values (4) Person who has disease under treatment now (5) Person with food and drug allergy (6) Person with anemia symptom (7) Those who have experienced ill mood or worsened physical condition by blood collection in the past (8) Those who donated more than 200 mL from the month before the start of the test to the start of the test, or those who have plans for it during the test period (9) Those who do intense sports and those who are on a diet (10) Person who has excessive smoking habit (11) Those who have an irregular diet (12) Those who can not quit the intake of health food (including food for specified health and functional indication food) and designated quasi-drugs during the test period (13) Those who are taking medication (including OTC and prescription drugs) continuously (14) Those who are taking alcohol excessively or who can not drink alcohol from the day before the test until the day (15) Persons who are pregnant or who are planning pregnancy or lactation during the study period (16) Those who are participating in or planning to participate in other clinical trials at the beginning of this trial, and within 4 weeks after the end of the trial (17) Others who are judged inappropriate by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Physical hand and physical examination Hematology and blood biochemistry Urinalysis Journal | — |
Countries
Japan
Contacts
Public ContactMegumi Takahashi
RYUSENDO CO., LTD. Development Office
Outcome results
None listed